FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely to ophthalmology, and is intended for the treatment of infectious and inflammatory eye diseases, including fungal lesions, ophthalmomycosis. The combined product contains thiotriazoline, decamethoxine, sodium chloride and purified water at the following ratio of components, wt. %: thiotriazoline 1.0; decamethoxine 0.01-0.02; sodium chloride 0.7; purified water the rest.
EFFECT: eye drops have high antifungal efficacy against C.albicans and high antimicrobial efficacy against pathogens resistant to known agents used in the treatment of infectious and inflammatory eye diseases, and also show a reduction in side effects compared to known agents.
1 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| GEL DROPS FOR TREATING INFLAMMATORY EYE DISEASES, INCLUDING INFECTIOUS AND SUSTAINABLE TO ANTIBIOTICS DISEASES | 2017 |
|
RU2669768C1 |
| METHOD FOR COMBATTING OTITIS MEDIA AND OTITIS EXTERNA | 2019 |
|
RU2749857C1 |
| METHOD FOR TREATMENT OF FUNGAL ULCER OF CORNEA | 2021 |
|
RU2802388C2 |
| METHOD OF TREATMENT OF CORNEA ULCERS OF PSEUDOMONAS AND GONOCOCCAL AETIOLOGY | 2006 |
|
RU2330633C1 |
| 2,4-DIOXO-5-(2-HYDROXY-3,5-DICHLOROBENZYLIDENE)IMINO-1,3-PYRIMIDINE SALTS | 2004 |
|
RU2260590C1 |
| COMPOSITION AND METHOD OF PRODUCING EYE DROPS | 2014 |
|
RU2595837C2 |
| THERAPEUTIC PREPARATION | 2000 |
|
RU2161961C1 |
| OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561048C1 |
| ANTIBACTERIAL DRUG IN FORM OF DROPS FOR TREATING EYE DISEASES IN ANIMALS | 2015 |
|
RU2580630C1 |
| DRUG FOR THE TREATMENT OF RESISTANT FUNGAL KERATITIS AND ITS METHOD OF USE | 2022 |
|
RU2790703C1 |
